IDEXX Laboratories, Inc. IDXX

519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IDEXX Laboratories, Inc. (IDXX) Operating margin

IDEXX Laboratories, Inc.'s operating margin over the twelve months to 30 June 2026 was 32.0%, up 0.4 percentage points from fiscal 2025 (31.6%). Over the past ten years it has ranged from 18.7% (fiscal 2015) to 31.6% (fiscal 2025) — the current reading is the highest in ten years. That is above the Diagnostics & Research industry median of −8.57% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 31.6% 2.65
FY2024 29.0% (1.02)
FY2023 30.0% 3.28
FY2022 26.7% (2.30)
FY2021 29.0% 3.33
FY2020 25.7% 2.69
FY2019 23.0% 0.77
FY2018 22.2% 1.22
FY2017 21.0% 1.25
FY2016 19.7% 1.01

Quarterly

Period Operating margin Change (points)
Jun 2026 35.0% 3.20
Mar 2026 31.8% 2.84
Dec 2025 28.9% (3.17)
Sep 2025 32.1% (1.51)
42 more quarters

Against its own ten years

Low 18.7% High 31.6%
Ten-year median 25.7%
Current reading's percentile 100

Operating margin against peers

Company Operating margin
IDXX IDEXX Laboratories, Inc. 32.0%
MTD Mettler-Toledo International, Inc. compare 28.4%
A Agilent Technologies, Inc. compare 22.2%
ILMN Illumina, Inc. compare 19.7%
DGX Quest Diagnostics Incorporated compare 14.1%
IQV IQVIA Holdings Inc. compare 13.0%
WAT Waters Corporation compare 7.10%
NTRA Natera, Inc. compare −10.7%
GH Guardant Health, Inc. compare −39.8%
Diagnostics & Research industry median −8.57%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on IDXX